Ingevity (NGVT) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Ingevity

NYSE•Basic Materials•Specialty Chemicals

$68.23+0.39(0.01%)Pre-market

Market Cap

$2.36B

P/E

43.7x

P/S

2.2x

P/B

50.3x

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

How this company scores

AverageMetricSide Score: 49/100

Strongest: Profitability (22/25); weakest: Balance Sheet & Red Flags (5/25).

Profitability22/25

Growth11/25

Balance Sheet & Red Flags5/25

Cash & Earnings Quality11/25

Strengths

Strong marginsHigh ROERising earningsProfit converts from growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 43.7x5y range 10.3x – 43.7x

Currently above its 10-quarter median.

P/S · 2.2x5y range 1.0x – 2.2x

Currently above its 20-quarter median.

P/B · 50.3x5y range 2.4x – 71.4x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg 0.4x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $2.36B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.09B
Q. Revenue: $314.10M
TTM EBITDA: $681.20M
TTM Op. Income: $580.60M
Q. Op. Income: $45.90M
TTM Net Income: $54.00M
Q. Net Income: $35.30M
EPS: $1.02
Shares Out.: $34.69M

$1.09B in TTM revenue declined 17.7% YoY, reaching $314.10M last quarter. TTM EBITDA of $681.20M and TTM operating income of $580.60M show growth is flowing through to the bottom line. TTM net income of $54.00M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has fallen for 7 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 44.3%
EBITDA Margin: 21.6%
Op. Margin: 14.6%
Net Margin: 11.2%

Op. margin of 14.6% is up 52.5% YoY — cost efficiency is improving. Net margin at 11.2% and gross margin of 44.3% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has fallen for 2 consecutive quarters — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 43.7x
P/S Ratio: 2.2x
P/B Ratio: 50.3x

At 43.7x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 2.2x and P/B of 50.3x provide additional context. P/E sits above typical market levels while revenue growth is below 5%.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.54B
Cash: $97.40M
Long-Term Debt: $1.06B
Book Value: $46.90M
D/E Ratio: 22.5
Debt/EBITDA: 15.6

With $1.54B in assets and $1.06B in long-term debt, D/E is 22.5and book value is $46.90M — elevated leverage, meaning significant financial risk in a downturn. Across the last 8 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-13.80M
TTM Free Cash Flow: $154.90M
FCF Margin: 14.2%
FCF / Net Income: 2.9

TTM FCF of $154.90M on $-13.80M in operating cash flow. The FCF / Net Income ratio of 2.9x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.